EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

KDM4B: A promising oncology therapeutic target

Fangjing Ni, Heting Tang, Siteng Cheng, Yaoyu Yu, Zhihao Yuan, Yingfei Chen, Encheng Zhang, Xiang Wang iD

Cancer Science · 2024-01 · 115 (1) · 8-16

DOI: 10.1111/cas.16005 ↗

At a glance

Übersichtsarbeit in Cancer Science, published online on 2023-11-03. Written by Fangjing Ni and 7 co-authors. Institution: Department of Urology, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China. Major MEDLINE topics: Neoplasms. Cited 15 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Epigenetic modifications are significant in tumor pathogenesis, wherein the process of histone demethylation is indispensable for regulating gene transcription, apoptosis, DNA replication, and repair of damaged DNA. The lysine demethylases (KDMs) serve an essential role in the aforementioned processes, with particular emphasis on the KDM4 family, also referred to as JMJD2. Multiple studies have underscored the significance of the KDM4 family in the regulation of various biological processes including, but not limited to, the cell cycle, DNA repair mechanisms, signaling pathways, and the progression of tumor formation. Nevertheless, it is imperative to elucidate the underlying mechanism of KDM4B, which belongs to the KDM4 gene family. This review presents a comprehensive examination of the structure, mechanism, and function of KDM4B, as well as a critical analysis of the current body of research pertaining to its involvement in tumorigenesis and development. Furthermore, this review explores the potential therapeutic strategies that specifically target KDM4B.

Subjects

MeSH terms (MEDLINE)

NeoplasmsHumansDNA RepairCell CycleSignal TransductionDNA ReplicationJumonji Domain-Containing Histone Demethylases

Author keywords

KDM4Bcancer therapeutic targetshistone demethylaseoncologyreview

Substances

KDM4B protein, humanJumonji Domain-Containing Histone Demethylases

Authors and institutions

  • Department of Urology, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.

ORCID profiles: Xiang Wang

Cite

APA

Ni, F., Tang, H., Cheng, S., Yu, Y., Yuan, Z., Chen, Y., Zhang, E., & Wang, X. (2024). KDM4B: A promising oncology therapeutic target. Cancer Science, 115(1), 8-16. https://doi.org/10.1111/cas.16005

Vancouver

Ni F, Tang H, Cheng S, Yu Y, Yuan Z, Chen Y, et al. KDM4B: A promising oncology therapeutic target. Cancer Science. 2024;115(1):8-16. doi:10.1111/cas.16005

BibTeX
@article{Ni2024,
  author = {Ni, Fangjing and Tang, Heting and Cheng, Siteng and Yu, Yaoyu and Yuan, Zhihao and Chen, Yingfei and Zhang, Encheng and Wang, Xiang},
  title = {KDM4B: A promising oncology therapeutic target},
  journal = {Cancer Science},
  year = {2024},
  volume = {115},
  number = {1},
  pages = {8--16},
  doi = {10.1111/cas.16005}
}
Start for free →